Vanguard Fiduciary Trust
EOLS icon

Vanguard Fiduciary Trust’s Evolus EOLS Stock Holding History

Vanguard Fiduciary Trust’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.17M Buy
456,183
+31,525
+7% +$186K ﹤0.01% 2435
2026
Q1 		$1.75M Buy
+424,658
New +$2.06M ﹤0.01% 2640

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Vanguard Fiduciary Trust's EOLS Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Evolus (EOLS) stake by 7.4% in Q2 2026, buying an estimated $186K and bringing the position to 456,183 shares worth $3.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2435.

Vanguard Fiduciary Trust first reported a position in EOLS in Q1 2026 and has held it in 2 quarters since. 157 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • Vanguard Fiduciary Trust held 456,183 shares of Evolus worth $3.17M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 31,525 Evolus shares in Q2 2026, an estimated $186K.
  • Evolus made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2435 holding.
  • Vanguard Fiduciary Trust first reported a position in Evolus in Q1 2026 and has held it in 2 quarters since.
  • 157 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.